X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ATHE

Closed

Alterity Therapeutics Ltd

4.0098
-0.0786 (-1.92%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.0884
Day's Range: 3.9 - 4.1686
Send
When Written:
 
2.7764
Alterity Therapeutics Ltd is a biotechnology company based in Australia that is focused on developing treatments for neurodegenerative diseases. The company's lead drug candidate, PBT434, is being developed to treat Parkinson's disease and other related disorders. PBT434 works by targeting the accumulation of iron in the brain, which is believed to contribute to the development of these diseases. Alterity Therapeutics also has a pipeline of other drug candidates targeting neurodegenerative diseases, including Alzheimer's disease and multiple system atrophy. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X